NEW YORK (GenomeWeb) – Despite their efficacy as gene-editing technologies, CRISPR/Cas9 and TALENs are still hampered by the potential for off-target activity, which can result in genome instability and impair normal gene function. But a new strategy reported this week, which had previously been developed for a related technology, promises to help researchers measure such unintended effects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.